Clinical trial
Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive…
NCT00429780 · Tehran University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00429780 |
|---|---|
| Title | Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0) |
| Official title | A Randomized, Safety, Immunogenicity & Efficacy Study of Autoclaved Leishmania Major Plus BCG vs. BCG (Double Blind) or Placebo (Open), in Healthy High Risk Iranian Volunteers With Positive Response to Leishmanin (LST>0) |
| Lead sponsor | Tehran University of Medical Sciences, Other |
| Collaborators | Pasteur Institute of Iran, Tehran, Iran Razi Vaccine and Serum Research Institute Centre for Disease Control & Management, Ministry of Health & Medical Education |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | Alum-ALM + BCG |
| Enrollment | 100 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 1, 2007 |
| Last update posted | Nov 18, 2009 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: